India’s interim budget 2024 furthers the government’s push for self-reliance with a hike in the allocation for production-linked incentive (PLI) schemes related to pharmaceuticals, support for green bio-production processes and innovation, as well as growth of medical colleges.
In continuation of a focus on specific diseases, like on sickle cell anemia in the fiscal year 2023-24 budget, this time the interim budget spoke about encouraging vaccination for nine to 14-year-old girls against
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?